Evidence map›Paper›PMID 26495109›Full record

ArticleJundishapur journal of microbiology2015

RPB5-Mediating Protein Suppresses Hepatitis B Virus (HBV) Transcription and Replication by Counteracting the Transcriptional Activation of Hepatitis B virus X Protein in HBV Replication Mouse Model.

Qiaoling Zhou, Feijun Huang, Lanlan Chen, Enqiang Chen, Lang Bai, Xing Cheng, Min He, Hong Tang

Open access · hybridAbstract read
In one paragraph

Article in Jundishapur journal of microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. mSphere · 2025
    Review
  2. Article
  3. Critical Involvement of TFIIB in Viral Pathogenesis.Frontiers in molecular biosciences · 2021
    Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Qiaoling ZhouCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, Republic of China ; Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, Republic of China.
Feijun HuangDepartment of Forensic Pathology, Medical School of Basic and Forensic Sciences, Sichuan University, Chengdu, Republic of China.
Lanlan ChenCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, Republic of China ; Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, Republic of China.
Enqiang ChenCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, Republic of China ; Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, Republic of China.
Lang BaiCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, Republic of China ; Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, Republic of China.
Xing ChengCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, Republic of China ; Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, Republic of China.
Min HeCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, Republic of China ; Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, Republic of China.
Hong TangCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, Republic of China ; Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, Republic of China.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRPB5-Mediating protein (RMP) is associated with the RNA polymerase II subunit RPB5. This protein functionally counteracts the transcriptional activation of Hepatitis B Virus X protein (HBx) by competitively binding to the RPB5; however, the effects of RMP on Hepatitis B virus (HBV) transcription and replication remain unknown.

objectivesThe purpose of this study was to investigate the effect of RMP on viral transcription and replication in vivo by using the hydrodynamic-based HBV replication mouse model. MATERIALS AND

methodsMale balb/c mice were transfected with wild type (1.2 wt) or the HBx minus HBV plasmids (1.2x (-)) with or without HBx and RMP, to establish an HBV replication mouse model by hydrodynamic injection through the tail vein. The HBV RNA and HBV DNA replication intermediates (RI) were analyzed in the liver.

resultsRPB5-Mediating protein could inhibit HBV transcription and replication in groups transfected with the 1.2 wt and HBx. The inhibitory effect disappeared in the 1.2x (-) groups, yet it reappeared in the groups co-transfected with 1.2x (-) and HBx. An inhibitory effect was indicated at a low dose of RMP (0.3 ug, 0.5 ug and 0.7 ug) compared to the control group and groups that had received high doses of RMP.

conclusionsOur study demonstrated that a low dose of RMP could inhibit HBV transcription and replication, which is dependent on the appearance of HBx in vivo.

Indexed as

Hepatitis B Virus X ProteinOrthohepadnavirusURI 1 ProteinVirus Replication

Identifiers

PMID26495109
PMCPMC4609327
OpenAlexW1912597733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.